Published by
@ShahidNShah
@ShahidNShah
December 6 to December 8, 2022
Amsterdam, Netherlands
Success of prostate cancer treatments has triggered a seismic shift in the status of the TRP field over the last year and sparked more research investment than ever before.
The Targeted Radiopharmaceuticals Summit Europe returns for its fourth year as the only event to address the needs of drug developers at all development stages, from both medical and operational perspectives.
Overcome the technical, logistical, and translational hurdles of radionuclide therapy development. This event will bring together clinical, logistical and manufacturing experts from radiopharma and academia to help you accelerate your development programmes, tackle supply chain issues and harness alpha- and beta- emitting radionuclides to take on new cancers.
Continue reading at targeted-radiopharma.com
December 6 to December 9, 2022
Hong Kong Convention and Exhibition Centre (HKCEC), 1 Expo Drive, Wan Chai, Hong Kong, Hong Kong
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 4, 2024 at 12:49pm